(Q35547652)

8 August 2017

1 reference

title

Linezolid pharmacokinetics in pediatric patients: an overview (English)

1 reference

8 August 2017

1 reference

1 reference

Gail L. Jungbluth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14520140

16 March 2024

Ian R. Welshman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14520140

16 March 2024

Nancy K. Hopkins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14520140

16 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14520140

16 March 2024

publication date

1 September 2003

1 reference

Pediatric Infectious Disease Journal

8 August 2017

1 reference

8 August 2017

22

1 reference

8 August 2017

9 Suppl

1 reference

8 August 2017

S153-7

1 reference

Impact of developmental pharmacology on pediatric study design: overcoming the challenges

8 August 2017

1

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

Antibacterial agents in pediatrics

16 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics

16 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

The stabilization and encapsulation of human growth hormone into biodegradable microspheres

16 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

Linezolid absolute bioavailability and the effect of food on oral bioavailability

16 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers

16 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

Linezolid: the first oxazolidinone antimicrobial

16 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections

16 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

Pharmacokinetics and tissue penetration of linezolid following multiple oral doses

16 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid

16 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

Intrapulmonary pharmacokinetics of linezolid

16 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement

16 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

Age and sex effects on the pharmacokinetics of linezolid

16 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

Single dose pharmacokinetics of linezolid in infants and children.

16 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

In vivo pharmacodynamics of a new oxazolidinone (linezolid)

16 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000086954.43010.63

16 March 2024

Identifiers

1 reference

8 August 2017

1 reference